September 2023 FDA Recall Drug by Amerisource Health Services Llc
D-0039-2024 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Amerisource Health Services Llc on September 1, 2023 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0039-2024

Reason for Recall
Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
Initiated
09-01-2023
Reported
10-11-2023
Quantity
3,344 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Amerisource Health Services LLC
Nationwide in the USA
HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11

Batch or Lot Expiration Information

Lot# : 1007002, Exp 12/31/2023